An Open-label, Drug Interaction Study to Investigate the Effects of Steady-State Fenofibric Acid on the Single-Dose Pharmacokinetics of Efavirenz in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 31 Jul 2012
At a glance
- Drugs Efavirenz (Primary) ; Fenofibric-acid (Primary)
- Indications HIV-1 infections; Hyperlipidaemia
- Focus Pharmacokinetics
- 31 Jul 2012 Additional lead trial investigator (Matthew Davis) identified as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2011 New trial record